The MucoTabs Project: Targeting the GI Tract with Mucoadhesive Oral Tablets
The MucoTabs Project: Targeting the GI Tract with Mucoadhesive Oral Tablets Introduction of the study Despite the widespread use of oral medicines, many drugs still face major challenges in achieving optimal absorption within the gastrointestinal tract. Oral administration remains the preferred route for drug delivery due to its simplicity, non-invasive nature, and high patient acceptance. […]
5 Reasons Pharma Is Outsourcing HPAPI and Complex Dosage Forms to European CDMOs
5 Reasons Pharma Is Outsourcing HPAPI and Complex Dosage Forms to European CDMOs The global shift toward CDMOs The global pharmaceutical industry is undergoing a profound transformation, with drug developers increasingly turning to contract development and manufacturing organizations (CDMOs). This shift is especially visible in Europe, where stricter regulatory expectations, pressure on costs, and the […]
Managing Right First Time from the ground up at Skyepharma
Managing Right First Time from the Ground up at Skyepharma Skyepharma, focused on Right First Time for the benefit of the customer At Skyepharma, we ensure Right First Time (RFT) for customers by leveraging the experience and skills of our production and quality technicians. This initiative is part of a global lean management project started in 2016 […]
Controlling the lag-time and release kinetics of press-coated tablets using process parameters and tablet geometry
Controlling the lag-time and release kinetics of press-coated tablets using process parameters and tablet geometry Abstract of the study Press-coated tablets are an advantageous technology to achieve delayed releases of active ingredients. They are characterized by a core–shell structure, that makes it possible to tune the lag-time and release kinetics in order to meet the […]
Collaboration Eneapharm & Skyepharma
Collaboration Eneapharm & Skyepharma Exciting new partnership for Skyehub-Bioproduction We are pleased to announce our collaboration with ENEAPHARM through the SKYEHUB platform. This partnership aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. With this collaboration, Skyepharma strengthens its positioning as a BIO CDMO, reinforcing its ambition […]
Rush Now and Regret Later or the Importance of Getting the Formulation Strategy Right from the Start
Rush Now and Regret Later or the Importance of Getting the Formulation Strategy Right from the Start How to choose the right CDMO from the start ? In the pharmaceutical industry, the road from an idea to a safe, effective, marketable solid oral dosage form can be full of technical challenges. Poor formulation choices early […]
4 Reasons Why Orphan Drugs Require a Specific Packaging Line
4 Reasons Why Orphan Drugs Require a Specific Packaging Line How to find the packaging facility that fits your orphan drug product ? Orphan drugs are developed to serve small, highly specific patient populations. They represent some of the most innovative and patient-critical therapies in the pharmaceutical industry. Yet despite their uniqueness, many orphan drugs […]
MucoTabS Reaches a Key Milestone with Official Patent Filing
MucoTabS Reaches a Key Milestone with Official Patent Filing Major milestone for MucoTabS, marked by the official filing of a patent securing this innovative technology Conducted as part of Pauline Tarlet’s doctoral research, supervised by Vanessa Bourgeaux (Head of Innovation at Skyepharma) and formerly by Marion Quaillet (Head of Project Managers), this program is carried […]
Skyepharma : The French CDMO Advances Strategic Growth Through Leadership and Shareholder Transition
Skyepharma : The French CDMO Advances Strategic Growth Through Leadership and Shareholder Transition Bertrand Simon and Hervé Letoublon acquire 100% of the company’s shares, Sébastien Mas becomes the new CEO of Skyepharma Skyepharma, a French CDMO (contract development and manufacturing organization), expert in solid oral forms and complex projects, has a remarkable story to tell. […]
Skyepharma Scientific Symposium 2025: “Advances in Overcoming Oral Dosage Form Development Challenges”.
Skyepharma’s Scientific Symposium 2025: “Advances in Overcoming Oral Dosage Form Development Challenges”. Julie AUFFRAY, Vanessa BOURGEAUX, Pascal GEORGE, Stéphanie BRIANCON, Claudia GAMA, Julien LEROUDIER, Hassan BENAMEUR, Quentin BOOULAY From groundbreaking advancements in drug delivery technologies to engaging discussions with industry leaders. Skyepharma has been a specialist in complex oral solid dosage forms for over 25 […]